Relmada Therapeutics (RLMD)
Nasdaq • RLMD • US75955J4022
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 26, 2026, ORTEX estimated 13.8% of free float sold short, 7.5 days to cover, cost to borrow 0.52%. Sign up for live short interest data.
Market Cap
455m USD | # 6141 in US
Volume
1.37m shares | 5.43m USD
Shares Outstanding
106.67m
Free Float Shares
77.47% | 82.64m
